<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药筛 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-22T20:45:07+08:00</updated>
  <subtitle>药品筛选</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>默克寄予厚望的PD-L1/TGFβ双抗，肺癌三期临床试验失败</title>
    <updated>2021-01-22T18:26:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/EB8O-4ABQpT7aZP7KRrJQA</id>
    <link href="https://mp.weixin.qq.com/s/EB8O-4ABQpT7aZP7KRrJQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>普瑞巴林口服液、泊沙康唑肠溶片首仿来了</title>
    <updated>2021-01-21T19:17:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/YLIejEKuwTkDXf0MnmWBsw</id>
    <link href="https://mp.weixin.qq.com/s/YLIejEKuwTkDXf0MnmWBsw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这个4+7集采独家中标品种，将新增3个企业过评价</title>
    <updated>2021-01-20T19:06:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/GGawI9ELbo_8IQoizIL8cw</id>
    <link href="https://mp.weixin.qq.com/s/GGawI9ELbo_8IQoizIL8cw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>广撒网策略：科伦仿制药品种线不断壮大</title>
    <updated>2021-01-19T19:00:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/GSSvNUTOC0R9nw44od4q7g</id>
    <link href="https://mp.weixin.qq.com/s/GSSvNUTOC0R9nw44od4q7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>扬子江药业 丙泊酚中/长链脂肪乳过评价 | 上周仿制药动态（1.11-1.17）</title>
    <updated>2021-01-18T14:04:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/65aTAYWyjHo65tx7mu2oZw</id>
    <link href="https://mp.weixin.qq.com/s/65aTAYWyjHo65tx7mu2oZw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>罗欣1类新药替戈拉生片上市申请，几个小而美仿制药将获批</title>
    <updated>2021-01-15T17:33:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/-YvAz3bP6Hjli-RpApC69Q</id>
    <link href="https://mp.weixin.qq.com/s/-YvAz3bP6Hjli-RpApC69Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>鸡贼和地方带量采购</title>
    <updated>2021-01-14T19:56:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/MGqe4Z8XGhbptHtuGzaJCw</id>
    <link href="https://mp.weixin.qq.com/s/MGqe4Z8XGhbptHtuGzaJCw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内首个CAR-T疗法，即将上市；多个重磅注射剂通过一致性评价</title>
    <updated>2021-01-12T20:07:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/BVhDkcmTeK1ARHkyoJOG3w</id>
    <link href="https://mp.weixin.qq.com/s/BVhDkcmTeK1ARHkyoJOG3w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>罗哌卡因、舒芬太尼、瑞芬太尼等多个麻醉镇痛药过评价 | 上周仿制药动态（1.4-1.10）</title>
    <updated>2021-01-11T17:22:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/xE3b58EdR_TJsxS9MbfN7Q</id>
    <link href="https://mp.weixin.qq.com/s/xE3b58EdR_TJsxS9MbfN7Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年底高峰：86个新批文、181个过评价  | 12月仿制药动态</title>
    <updated>2021-01-06T16:35:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/9Zekveb8Qk5OACBSTLkLhg</id>
    <link href="https://mp.weixin.qq.com/s/9Zekveb8Qk5OACBSTLkLhg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>